本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Metagenomi Technologies, LLC

1.66
-0.0100-0.60%
成交量:30.92万
成交额:49.72万
市值:6,205.66万
市盈率:-0.70
高:1.71
开:1.70
低:1.55
收:1.67
数据加载中...

公司资料

公司名字:
Metagenomi Technologies, LLC
交易所:
NASDAQ
成立时间:
2016
员工人数:
202
公司地址:
5959 Horton Street,7th Floor,Emeryville,California,United States
邮编:
94608
电话:
传真:
- -
简介:
Metagenomi, Inc.于2016年9月在特拉华州注册成立。该公司是一家精准基因药物公司,致力于使用专有的、全面的宏基因组学衍生的基因组编辑工具箱为患者开发治疗药物。遗传病是由一系列不同的突变引起的,这些突变迄今为止在很大程度上是基因组工程方法所无法获得的。基因突变以多种形式出现,包括缺失、插入、单碱基对变化和序列重复,在整个基因组中以及在各种不同的细胞类型、组织和器官系统中都有发现。

董事

名称
职位
Brian C. Thomas
Chief Executive Officer and Director
Jian Irish
President and Chief Operating Officer and Director
Juergen Eckhardt
Director
Sebastián Bernales
Director
Willard Dere
Director

股东

名称
职位
Brian C. Thomas
Chief Executive Officer and Director
Jian Irish
President and Chief Operating Officer and Director
Alan Brooks
Senior Vice President of Preclinical
Pamela Wapnick
Chief Financial Officer
Simon Harnest
Chief Investment Officer and Senior Vice President of Strategy
Christopher T. Brown
Vice President of Discovery
Luis G. Borges
Chief Scientific Officer
Matthew L. Wein
Vice President of Corporate Legal and Compliance and Corporate Secretary
Michael Conway
Vice President of Finance
Sarah Noonberg
Chief Medical Officer
Simren Delaney
Vice President of Intellectual Property and Legal Operations